Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG)

OBJECTIVES: The choice of drug treatment in advanced soft tissue sarcoma (STS) continues to be a challenge regarding efficacy, quality of life (QoL) and toxicity. Unlike other cancer types, where integrating patient-reported outcomes (PRO) has proven to be beneficial for QoL, there is no such eviden...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Hentschel, Leopold, Richter, Stephan, Kopp, Hans-Georg, Kasper, Bernd, Kunitz, Annegret, Grünwald, Viktor, Kessler, Torsten, Chemnitz, Jens Marcus, Pelzer, Uwe, Schuler, Ulrich, Freitag, Janet, Schilling, Andrea, Hornemann, Beate, Arndt, Karin, Bornhäuser, Martin, Schuler, Markus Kajo
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Palliative Care
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7454199/
https://ncbi.nlm.nih.gov/pubmed/32859662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-035546
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados